Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639106 · ClinicalTrials.gov registry record · Phase 3
Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 70
- Enrollment target
NCT00639106: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00639106 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639106, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 70 participants
- Enrollment target
Study Summary
Following mastectomy (removal of your breast), reconstruction of your breast(s) can be performed using tissue expanders and implants. At the same operation as your mastectomy, a tissue expander is put under the skin and muscles of your chest. Following your surgery, the tissue expander is gradually filled with salt water over a period of months. Once the expander is filled to the size of your new breast, a second operation is performed. At this time, the tissue expander is removed and a permanent breast implant is placed. This is a standard procedure. We are interested in learning about the use of AlloDerm in breast reconstruction. AlloDerm can be used instead of some of your own chest muscles, in order to cover and protect a tissue expander. We want to know if the use of AlloDerm can decrease your pain or discomfort after surgery and after the filling of your tissue expander. AlloDerm is made from human tissue. When AlloDerm is made all the cells that could cause your body to reject it are removed. When it is placed in your chest, your own cells will then grow into the AlloDerm, causing it to act like the muscle it is replacing. In this study, you will either have reconstruction with AlloDerm or without AlloDerm.
Interventions
- PROCEDURE Alloderm, Questionnaires
- PROCEDURE Without ALLODERM, Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-03 |
| Est. Completion | 2018-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639106
The ClinicalTrials.gov registry entry for NCT00639106 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alloderm, Questionnaires is the first listed.
NCT00639106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00639106 about?
NCT00639106 is a clinical study titled "Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial". Following mastectomy (removal of your breast), reconstruction of your breast(s) can be performed using tissue expanders and implants. At the same operation as your mastectomy, a tissue expander is put under the skin and muscles of your chest. Following your surgery, the tissue expander is gradually...
What is the current status of trial NCT00639106?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 70 participants. The study started on 2008-03. Estimated completion is 2018-10.
What interventions are being tested in trial NCT00639106?
The interventions under investigation include: Alloderm, Questionnaires (PROCEDURE), Without ALLODERM, Questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT00639106?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.